Biomerica Financial Statements From 2010 to 2025

BMRA Stock  USD 0.70  0.08  12.90%   
Biomerica financial statements provide useful quarterly and yearly information to potential Biomerica investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Biomerica financial statements helps investors assess Biomerica's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Biomerica's valuation are summarized below:
Gross Profit
446 K
Profit Margin
(1.12)
Market Capitalization
5.5 M
Enterprise Value Revenue
1.7584
Revenue
5.5 M
We have found one hundred twenty available fundamental signals for Biomerica, which can be analyzed and compared to other ratios and to its rivals. All investors should make sure to validate all of Biomerica prevailing market performance against the performance between 2010 and 2025 to make sure the company can sustain itself down the road. The current year's Market Cap is expected to grow to about 10.3 M. The current year's Enterprise Value is expected to grow to about 9.1 M

Biomerica Total Revenue

7.58 Million

Check Biomerica financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Biomerica's main balance sheet or income statement drivers, such as Depreciation And Amortization of 212 K, Interest Expense of 32.2 K or Selling General Administrative of 6 M, as well as many indicators such as Price To Sales Ratio of 2.74, Dividend Yield of 0.0 or PTB Ratio of 2.3. Biomerica financial statements analysis is a perfect complement when working with Biomerica Valuation or Volatility modules.
  
Check out the analysis of Biomerica Correlation against competitors.
For information on how to trade Biomerica Stock refer to our How to Trade Biomerica Stock guide.

Biomerica Balance Sheet

Current ValueLast YearHistorical Average 10 Year Trend
Total Assets7.4 M10.6 M8.5 M
Slightly volatile
Other Current Liabilities1.4 M1.4 M616.4 K
Slightly volatile
Total Current Liabilities1.3 MM1.2 M
Slightly volatile
Total Stockholder Equity4.5 M7.6 M6.8 M
Slightly volatile
Property Plant And Equipment Net693.1 K1.1 M834.5 K
Slightly volatile
CashM4.8 M3.7 M
Slightly volatile
Non Current Assets Total1.4 M1.8 M1.4 M
Slightly volatile
Non Currrent Assets Other166.8 K182.7 K118.3 K
Slightly volatile
Cash And Short Term InvestmentsM4.8 M3.7 M
Slightly volatile
Net Receivables950.1 K852.3 KM
Very volatile
Common Stock Shares Outstanding20.3 M19.3 M10.7 M
Slightly volatile
Liabilities And Stockholders Equity7.4 M10.6 M8.5 M
Slightly volatile
Inventory2.2 M2.7 M2.1 M
Slightly volatile
Other Current Assets285.8 K214.2 K338 K
Very volatile
Other Stockholder Equity64.7 M61.6 M32.2 M
Slightly volatile
Total Liabilities1.5 M2.4 M1.5 M
Slightly volatile
Property Plant And Equipment Gross3.9 M3.7 M1.6 M
Slightly volatile
Total Current AssetsM8.9 M7.1 M
Slightly volatile
Accounts Payable246.2 K259.2 K451.3 K
Very volatile
Short and Long Term Debt Total688.4 K706.5 K1.5 M
Slightly volatile
Short Term Debt476.5 K293.4 K379.3 K
Pretty Stable
Intangible Assets273.3 K190.8 K291.7 K
Slightly volatile
Common Stock Total Equity622.7 K1.1 M756.2 K
Slightly volatile
Common Stock1.6 M1.5 M892.8 K
Slightly volatile
Other Assets86.3 K90.8 K169.5 K
Slightly volatile
Property Plant Equipment1.5 M1.4 M937.1 K
Slightly volatile
Current Deferred Revenue72.7 K76.5 K70.3 K
Slightly volatile
Net Tangible Assets7.8 M13.3 M7.5 M
Slightly volatile
Capital Surpluse24.5 M42.2 M26.5 M
Slightly volatile
Long Term Investments132.2 K148.5 K162.2 K
Slightly volatile
Deferred Long Term Asset Charges35.1 K36.9 K159.2 K
Slightly volatile
Net Invested Capital8.6 M7.6 M6.6 M
Slightly volatile
Net Working Capital7.6 M6.4 M5.7 M
Slightly volatile
Capital Stock1.2 M1.5 M960.5 K
Slightly volatile
Capital Lease Obligations1.1 M706.5 K1.5 M
Slightly volatile
Non Current Liabilities OtherM1.2 M1.3 M
Slightly volatile

Biomerica Income Statement

Current ValueLast YearHistorical Average 10 Year Trend
Depreciation And Amortization212 K336.6 K284.1 K
Slightly volatile
Selling General AdministrativeM6.3 M3.1 M
Slightly volatile
Total Revenue7.6 M6.2 M6.5 M
Slightly volatile
Gross Profit522.4 K549.9 K1.4 M
Slightly volatile
Other Operating Expenses8.9 M13.5 M9.2 M
Slightly volatile
Cost Of RevenueM5.5 M4.9 M
Slightly volatile
Total Operating Expenses8.4 MM4.5 M
Slightly volatile
Research Development1.8 M1.7 M1.3 M
Slightly volatile
Minority Interest27.2 K23.4 K26 K
Pretty Stable
Non Operating Income Net Other44.1 K76.9 K45.6 K
Slightly volatile
Interest Income520.4 K495.6 K126 K
Slightly volatile
Net Interest Income520.4 K495.6 K126.6 K
Slightly volatile
Reconciled Depreciation366.2 K430.1 K298.4 K
Slightly volatile
Selling And Marketing Expenses9781.1 K1.2 K
Slightly volatile

Biomerica Cash Flow Statement

Current ValueLast YearHistorical Average 10 Year Trend
Begin Period Cash Flow11.7 M11.2 MM
Slightly volatile
Depreciation219.8 K336.6 K275.6 K
Slightly volatile
End Period Cash FlowM4.8 M3.4 M
Slightly volatile
Stock Based CompensationM962.5 K467.4 K
Slightly volatile

Financial Ratios

Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio2.742.073.0884
Slightly volatile
PTB Ratio2.31.332.908
Pretty Stable
Days Sales Outstanding71.3973.4168.4422
Pretty Stable
Book Value Per Share0.430.450.6795
Pretty Stable
Average Payables716.2 K1.1 M641.9 K
Slightly volatile
Stock Based Compensation To Revenue0.150.140.0664
Slightly volatile
Capex To Depreciation0.260.280.6679
Slightly volatile
PB Ratio2.31.332.908
Pretty Stable
EV To Sales2.311.362.6387
Slightly volatile
Inventory Turnover1.822.02192.269
Pretty Stable
Days Of Inventory On Hand139162172
Slightly volatile
Payables Turnover15.7615.0112.7171
Pretty Stable
Sales General And Administrative To Revenue0.00210.00240.0026
Slightly volatile
Average Inventory2.1 M2.5 M2.1 M
Slightly volatile
Research And Ddevelopement To Revenue0.260.250.1998
Slightly volatile
Capex To Revenue0.02060.01910.0265
Slightly volatile
Cash Per Share0.390.290.3068
Slightly volatile
Days Payables Outstanding23.9125.1635.6007
Very volatile
Income Quality0.850.811.183
Slightly volatile
Intangibles To Total Assets0.0250.02630.0288
Slightly volatile
Current Ratio3.753.166.5869
Slightly volatile
Tangible Book Value Per Share0.410.440.657
Pretty Stable
Receivables Turnover5.145.156.5547
Pretty Stable
Shareholders Equity Per Share0.760.450.7001
Pretty Stable
Debt To Equity0.130.140.1151
Slightly volatile
Capex Per Share0.00750.00790.0179
Slightly volatile
Graham Net Net0.250.180.3557
Very volatile
Average Receivables1.3 M1.3 M1.2 M
Slightly volatile
Revenue Per Share0.350.370.6674
Slightly volatile
Interest Debt Per Share0.0510.05370.0414
Slightly volatile
Debt To Assets0.130.09760.0929
Slightly volatile
Graham Number0.751.081.1187
Very volatile
Operating Cycle261281247
Pretty Stable
Price Book Value Ratio2.31.332.908
Pretty Stable
Days Of Payables Outstanding23.9125.1635.6007
Very volatile
Company Equity Multiplier2.571.611.3103
Slightly volatile
Long Term Debt To Capitalization0.00940.00990.027
Slightly volatile
Total Debt To Capitalization0.240.120.1094
Slightly volatile
Debt Equity Ratio0.130.140.1151
Slightly volatile
Quick Ratio2.262.194.2708
Slightly volatile
Net Income Per E B T0.620.910.9636
Very volatile
Cash Ratio1.441.72.662
Very volatile
Cash Conversion Cycle148200202
Slightly volatile
Days Of Inventory Outstanding139162172
Slightly volatile
Days Of Sales Outstanding71.3973.4168.4422
Pretty Stable
Price To Book Ratio2.31.332.908
Pretty Stable
Fixed Asset Turnover6.276.69.5363
Slightly volatile
Debt Ratio0.130.09760.0929
Slightly volatile
Price Sales Ratio2.742.073.0884
Slightly volatile
Asset Turnover1.230.670.8946
Pretty Stable
Gross Profit Margin0.120.130.2406
Slightly volatile
Price Fair Value2.31.332.908
Pretty Stable

Biomerica Valuation Data

Current ValueLast YearHistorical Average 10 Year Trend
Market Cap10.3 M8.8 M20.3 M
Slightly volatile
Enterprise Value9.1 M5.7 M17.7 M
Pretty Stable

Biomerica Fundamental Market Drivers

Cash And Short Term Investments4.2 M

Biomerica Upcoming Events

12th of April 2024
Upcoming Quarterly Report
View
29th of February 2024
Next Fiscal Quarter End
View

About Biomerica Financial Statements

Biomerica stakeholders use historical fundamental indicators, such as Biomerica's revenue or net income, to determine how well the company is positioned to perform in the future. Although Biomerica investors may analyze each financial statement separately, they are all interrelated. For example, changes in Biomerica's assets and liabilities are reflected in the revenues and expenses on Biomerica's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Biomerica. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Current Deferred Revenue76.5 K72.7 K
Total Revenue6.2 M7.6 M
Cost Of Revenue5.5 MM
Stock Based Compensation To Revenue 0.14  0.15 
Research And Ddevelopement To Revenue 0.25  0.26 
Capex To Revenue 0.02  0.02 
Revenue Per Share 0.37  0.35 
Ebit Per Revenue(1.35)(1.28)

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether Biomerica offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Biomerica's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Biomerica Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Biomerica Stock:
Check out the analysis of Biomerica Correlation against competitors.
For information on how to trade Biomerica Stock refer to our How to Trade Biomerica Stock guide.
You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Biomerica. If investors know Biomerica will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Biomerica listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.37)
Revenue Per Share
0.327
Quarterly Revenue Growth
0.055
Return On Assets
(0.39)
Return On Equity
(0.76)
The market value of Biomerica is measured differently than its book value, which is the value of Biomerica that is recorded on the company's balance sheet. Investors also form their own opinion of Biomerica's value that differs from its market value or its book value, called intrinsic value, which is Biomerica's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Biomerica's market value can be influenced by many factors that don't directly affect Biomerica's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Biomerica's value and its price as these two are different measures arrived at by different means. Investors typically determine if Biomerica is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Biomerica's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.